Investment Rating - The report maintains a "Buy" rating for the company, with expected net profits of 164 million, 198 million, and 228 million yuan for 2024, 2025, and 2026 respectively, reflecting growth rates of 16.0%, 20.6%, and 15.3% [3][18]. Core Insights - The company is a leader in the sensitive toothpaste market, leveraging its flagship brand "Cold Acid Spirit" to expand its product offerings and enhance consumer engagement. The company has a strong market presence with over 60% market share in the sensitive toothpaste segment [15][29]. - The oral care industry shows strong growth resilience, with a compound annual growth rate (CAGR) of 2.8% from 2018 to 2023. The market is characterized by high concentration, with domestic brands gaining market share at the expense of foreign brands [3][18]. - The company is actively expanding its online sales channels, which accounted for 22.92% of revenue in the first half of 2024, indicating a significant shift towards e-commerce in the oral care sector [3][18]. Summary by Sections Company Overview - The company focuses on oral health and beauty solutions, with a comprehensive product range including toothpaste, toothbrushes, mouthwash, and emerging categories like electric toothbrushes and oral disinfectants. The brand "Cold Acid Spirit" has maintained a leading position in the sensitive toothpaste market with a retail market share of 62.92% in the first half of 2024 [15][29]. Industry Analysis - The oral care market is driven by essential consumer needs, showing resilience even during economic downturns. The market size for oral care products reached 49.15 billion yuan in 2023, with a steady growth trajectory expected as consumer awareness of oral health increases [3][18]. Growth Strategy - The company is enhancing its product matrix by expanding categories and optimizing product structures. The adult oral care segment remains the primary revenue driver, while children's oral care and electric products are rapidly growing segments [3][18]. Financial Performance - The company has demonstrated strong financial growth, with revenues increasing from 944 million yuan in 2019 to 1.376 billion yuan in 2023, representing a CAGR of 9.88%. The net profit has also shown significant growth, with a CAGR of 22.30% during the same period [3][18].
登康口腔：抗敏龙头，性价比优势凸显，线上化存想象空间